Tag: Paroxysmal nocturnal hemoglobinuria

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Paroxysmal nocturnal hemoglobinuria

AstraZeneca expands global footprint in rare disease with availability of first Alexion ... - Cision News

Added to Collection on: 2022-11-11 07:19:06

Tags for this article:

Medical specialties
Medicine
Health
Rare diseases
Blood disorders
Acquired hemolytic anemia
Alexion Pharmaceuticals
Eculizumab
Atypical hemolytic uremic syndrome
Paroxysmal nocturnal hemoglobinuria
Hemolytic anemia
Neuromyelitis optica
Soliris
Alexion Pharmaceuticals Inc.
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca bringing rare disease medicine to patients in China - BioPharma-Reporter

Added to Collection on: 2022-11-14 18:22:21

Tags for this article:

Medical specialties
Medicine
Rare diseases
Organ systems
Blood disorders
Acquired hemolytic anemia
Autoimmune diseases
Atypical hemolytic uremic syndrome
Syndromes
Eculizumab
Paroxysmal nocturnal hemoglobinuria
Hemolytic–uremic syndrome
Soliris

Click the tags to see associated articles and topics

View Article Details
Iptacopan Bests Standard of Care Therapy for PNH Patients - HCPLive

Added to Collection on: 2022-12-13 14:18:40

Tags for this article:

Medical specialties
Medicine
Blood
Transfusion medicine
Acquired hemolytic anemia
Hematopathology
Hematology
Autoimmune diseases
Paroxysmal nocturnal hemoglobinuria
Eculizumab
Hemoglobinuria
Hemolysis

Click the tags to see associated articles and topics

View Article Details
Paroxysmal Nocturnal Hemoglobinuria Therapeutics Market Huge Growth in Future Scope ...

Added to Collection on: 2022-12-24 13:14:02

Tags for this article:

Articles
Health
Rare diseases
Alexion Pharmaceuticals
Paroxysmal attack
Hemoglobinuria
Market research
Paroxysmal nocturnal hemoglobinuria
Pharmaceutical industry in China
Market segmentation
Marketing strategy

Click the tags to see associated articles and topics

View Article Details
Paroxysmal Nocturnal Hemoglobinuria Market is Expected - openPR.com

Added to Collection on: 2024-05-01 15:57:31

Tags for this article:

Immunosuppressants
Orphan drugs
Hematology
Monoclonal antibodies
Complement system
Pegcetacoplan
Alexion Pharmaceuticals
PNH
Danicopan
Paroxysmal nocturnal hemoglobinuria
Crovalimab
Eculizumab

Click the tags to see associated articles and topics

View Article Details
FDA clears Amgen's Bkemv as first biosimilar of Soliris - Pharmaphorum

Added to Collection on: 2024-05-29 21:48:08

Tags for this article:

Orphan drugs
Monoclonal antibodies
Acquired hemolytic anemia
Immunosuppressants
Eculizumab
Hemolytic–uremic syndrome
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Amgen
Alexion Pharmaceuticals
United States
Soliris

Click the tags to see associated articles and topics

View Article Details
Amgen's rare-disease treatment biosimilar Bkemv gets FDA approval | Morningstar

Added to Collection on: 2024-05-29 10:54:38

Tags for this article:

Acquired hemolytic anemia
Blood disorders
Alexion Pharmaceuticals
AstraZeneca
Nephrology
Eculizumab
Hemolysis
Hemolytic–uremic syndrome
Thrombotic microangiopathy
Hematologic disease
Paroxysmal nocturnal hemoglobinuria
Amgen
Soliris

Click the tags to see associated articles and topics

View Article Details
Two novel biosimilars approved in EU and US - European Pharmaceutical Review

Added to Collection on: 2024-05-29 16:41:40

Tags for this article:

Monoclonal antibodies
Acquired hemolytic anemia
Orphan drugs
Immunosuppressants
Eculizumab
Omalizumab
Alexion Pharmaceuticals
Paroxysmal nocturnal hemoglobinuria
Celltrion
Hemolytic–uremic syndrome
Thrombotic microangiopathy
Hemolysis

Click the tags to see associated articles and topics

View Article Details
Voydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults ... - Placera

Added to Collection on: 2024-07-23 17:05:58

Tags for this article:

Orphan drugs
Immunosuppressants
Monoclonal antibodies
Hematology
Rare diseases
Eculizumab
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Alexion Pharmaceuticals
Danicopan
Hemolytic anemia
Hemolysis
Soliris

Click the tags to see associated articles and topics

View Article Details
NICE recommendation for new Alexion PNH treatment - PharmaTimes

Added to Collection on: 2024-10-24 15:34:41

Tags for this article:

Orphan drugs
Monoclonal antibodies
Immunosuppressants
Rare diseases
Complement system
Ravulizumab
Paroxysmal nocturnal hemoglobinuria
Eculizumab
Hemolysis
Hemolytic anemia
Factor D
AstraZeneca
Alexion

Click the tags to see associated articles and topics

View Article Details